Compugen (CGEN) SVP Levine exercises options and sells 1,875 shares under plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Compugen Ltd senior vice president of business development Zurit Levine exercised options to acquire 1,875 Ordinary Shares at $0.8292 per share and, on the same date, sold 1,875 Ordinary Shares at $2.50 per share in an open-market transaction. The trades were made pursuant to a Rule 10b5-1 trading plan adopted on December 23, 2025. Following these transactions, Levine directly holds 29,375 Ordinary Shares and 3,750 share options with a $0.8292 exercise price expiring on November 9, 2032.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 1,875 shares ($4,688)
Net Sell
3 txns
Insider
Levine Zurit
Role
SVP, Business Development
Sold
1,875 shs ($5K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Share Option (right to buy) | 1,875 | $0.00 | -- |
| Exercise | Ordinary Shares | 1,875 | $0.8292 | $2K |
| Sale | Ordinary Shares | 1,875 | $2.50 | $5K |
Holdings After Transaction:
Share Option (right to buy) — 3,750 shares (Direct);
Ordinary Shares — 31,250 shares (Direct)
Footnotes (1)
- This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. This option vested 25% on December 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
Key Figures
Shares sold: 1,875 Ordinary Shares
Sale price: $2.50 per share
Options exercised: 1,875 Ordinary Shares
+3 more
6 metrics
Shares sold
1,875 Ordinary Shares
Open-market sale on July 9, 2026 at $2.50 per share
Sale price
$2.50 per share
Price received for 1,875 Ordinary Shares sold on July 9, 2026
Options exercised
1,875 Ordinary Shares
Shares acquired via option exercise on July 9, 2026
Exercise price
$0.8292 per share
Exercise price of options converted into 1,875 Ordinary Shares
Shares held after
29,375 Ordinary Shares
Direct ownership after the reported transactions
Options remaining
3,750 share options
Direct derivative holdings after exercise; strike $0.8292, expire November 9, 2032
Key Terms
Rule 10b5-1 trading plan, derivative security, Share Option (right to buy)
3 terms
Rule 10b5-1 trading plan financial
"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
What did Compugen (CGEN) executive Zurit Levine report in this Form 4?
Zurit Levine reported exercising options for 1,875 Ordinary Shares at $0.8292 and selling 1,875 Ordinary Shares at $2.50 on July 9, 2026, in open-market transactions under a Rule 10b5-1 plan.
At what prices did Zurit Levine trade Compugen (CGEN) stock in this filing?
Levine exercised options at $0.8292 per share and sold Ordinary Shares at $2.50 per share. The option exercise and share sale both involved 1,875 shares on July 9, 2026.
Were the Compugen (CGEN) trades by Zurit Levine under a Rule 10b5-1 plan?
Yes. A footnote states the share sale was made pursuant to a Rule 10b5-1 trading plan adopted by Zurit Levine on December 23, 2025, indicating the trade was pre-arranged.
What options does Zurit Levine still hold in Compugen (CGEN)?
Levine holds 3,750 share options with a $0.8292 exercise price, expiring on November 9, 2032. The options vested 25% on December 31, 2023, with the remainder in 12 equal quarterly installments.
What role does Zurit Levine hold at Compugen (CGEN)?
Zurit Levine is an officer of Compugen, serving as Senior Vice President, Business Development, according to the insider information disclosed alongside the reported transactions.